Founded in August 2015, Hikma Ventures operates as the corporate venture capital arm of Hikma Pharmaceuticals.
Our primary focus is to identify and invest in emerging companies in the digital health space, globally, that could enhance Hikma’s value proposition, reputation and market intelligence.
We will also consider investments in other healthcare related areas of current or future strategic interest to Hikma, including drug delivery technologies that have the potential to enhance Hikma's value chain and pipeline.
HV will act as an instrument of strategic growth in broadening Hikma’s offerings; it will allow Hikma to tap into opportunities in the growing digital healthspace.
HV will invest in companies where Hikma's expertise can accelerate revenue growth and enhance value creation by providing ventures with access to the resources of a multinational pharmaceutical company.
We will invest in companies at all stages of development, including start-ups. HV looks at global opportunities.
Our initial investment size is up to $5 million per round.
We seek to actively partner with the management teams of portfolio companies to realize the potential of their products and technologies.
Hikma Ventures has invested and continues to invest in companies in the digital health space, globally, that have the potential to enhance ours value chain and pipeline.
Our primary focus is to identify and invest in emerging companies in the digital health space, globally, that could enhance Hikma’s value proposition, reputation and market intelligence.
We will also consider investments in other healthcare related areas of current or future strategic interest to Hikma, including drug delivery technologies that have the potential to enhance Hikma's value chain and pipeline.
HV will act as an instrument of strategic growth in broadening Hikma’s offerings; it will allow Hikma to tap into opportunities in the growing digital healthspace.
HV will invest in companies where Hikma's expertise can accelerate revenue growth and enhance value creation by providing ventures with access to the resources of a multinational pharmaceutical company.
We will invest in companies at all stages of development, including start-ups. HV looks at global opportunities.
Our initial investment size is up to $5 million per round.
We seek to actively partner with the management teams of portfolio companies to realize the potential of their products and technologies.
Hikma Ventures has invested and continues to invest in companies in the digital health space, globally, that have the potential to enhance ours value chain and pipeline.
Location: United Kingdom, England, Westminster
Employees: 1-10
Founded date: 2015
Investment Type: Venture Capital
Portfolio 1
| Date | Name | Website | Total Raised | Location |
| 11.05.2023 | Prognos He... | prognoshealth.com | $23M | United Sta... |
Mentions in press and media 22
| Date | Title | Description |
| 23.04.2025 | Biolinq's $100 Million Leap: A New Era for Diabetes Management | In the world of health technology, innovation is the lifeblood. Biolinq, a California-based company, has just injected a hefty $100 million into its vision for the future of diabetes management. This Series C funding round, led by Alpha Wav... |
| 22.04.2025 | Biolinq Raises $100M to Expand Biowearable Platform for Metabolic Health | What You Should Know: – Biolinq, a healthcare technology company focused on developing precision multi-analyte biosensors to improve metabolic health raises $100M in Series C financing round led by Alpha Wave Ventures, with participation fr... |
| 07.04.2022 | Egypt’s O7 Therapy lands game-changing $2.1M in funding | Credit: O7 Therapy |
| 01.04.2022 | Additional $14 million for Altoida to advance its neurocognitive assessment platform | |
| 26.08.2020 | SeamlessMD raises $4 million CAD Series A to meet increased demand for digital patient engagement due to COVID-19 | Toronto healthtech startup SeamlessMD, which provides a cloud-based patient engagement app, has raised a $4 million CAD Series A round led by Montreal’s MEDTEQ+, a federally and provincially-funded Quebec non-profit that invests in medical ... |
| 31.07.2020 | Lemonaid Health Raises $33M to Expand On-Demand Consumer Telehealth Platform | What You Should Know: – Lemonaid Health, a direct to consumer telehealth company raises $33M in Series B funding to expand the company’s medical team and number of services being offered to patients. – To date, the company has treated more ... |
| 05.05.2020 | Hikma Ventures invests in Altoida | |
| 05.05.2020 | Hikma Ventures invests in Altoida | The number of people living with Alzheimer's disease is rapidly growing. In 2019 alone, Alzheimer's disease and other dementias cost the US $290 billion. By 2050, these costs could rise as high as $1.1 trillion, according to the 2019 Facts ... |
| 25.11.2019 | Today in funding ($10.26 million): Winterlight Labs, Casca | Two Canadian startups have announced fresh funding rounds to fuel their growth. Here’s the latest on who raised how much, from whom, and what they’ll be putting the new funds toward. Winterlight Labs raises $5.6 million CAD in Series A fund... |
| 29.05.2019 | Pillo Health Raises $11M to Expand Personal Home Health Robot | Pillo Health, a Boston-based digital health company improving longevity and quality of life for patients managing their health at home has raised $11M in Series A funding, led by Stanley Black & Decker’s corporate venture capital arm wi... |
Show more